Black Diamond Therapeutics Inc Stock Performance
as on April 21, 2026 at 6:59 am IST
Day's Low
Day's High
$2.98$3.17
2.61%
Downside
3.59%
Upside
52 Week's Low
52 Week's High
$1.39$4.9454.58%
Downside
61.44%
Upside
Black Diamond Therapeutics Inc share price movements today
- Previous Close
- $3.06
- Open
- $3.04
- Volume
- 1.1M
- Day's Low - High
- $2.98 - $3.17
- 52 Week Low - High
- $1.39 - $4.94
Black Diamond Therapeutics Inc Historical Returns
- 1 Month Return
- + 44.55 %
- 3 Month Return
- + 18.68 %
- 1 Year Return
- + 104.7 %
- 3 Year Return
- + 93.04 %
- 5 Year Return
- -88.32 %
Black Diamond Therapeutics Inc Stock Fundamentals & Key Indicators
Check Black Diamond Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$174.7M
EPS (TTM)
-0.6386
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
7.82
Industry PE ratio
-3.202596153846154
PEG Ratio
0EBITDA
20.2M
Revenue (TTM)
70.0M
Profit Margin
31.95%
Return On Equity TTM
22.88%
Black Diamond Therapeutics Inc Stock Valuation
Track how Black Diamond Therapeutics Inc P/E has moved over time to understand its valuation trends.
Black Diamond Therapeutics Inc in the last 5 years
Lowest (-6.77x)
June 30, 2021
Industry (-3.20x)
April 21, 2026
Today (7.82x)
April 21, 2026
Highest (32.41x)
March 31, 2025
Today’s Price to Earnings Ratio: 7.82x
Black Diamond Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Black Diamond Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $174.7M | -88.32% | 7.82 | 31.95% | |
| BUY | $41.3B | 126.09% | 133.47 | 8.45% | |
| BUY | $111.7B | 99.85% | 28.65 | 32.94% | |
| NA | $36.5B | NA | 128.25 | 5.37% | |
| BUY | $79.2B | 47.96% | 18.05 | 31.41% |
Stock Returns calculator for Black Diamond Therapeutics Inc Stock including INR - Dollar returns
The Black Diamond Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Black Diamond Therapeutics Inc investment value today
Current value as on today
₹2,24,481
Returns
₹1,24,481
(+124.48%)
Returns from Black Diamond Therapeutics Inc Stock
₹1,05,369 (+105.37%)
Dollar Impact
₹19,112 (+19.11%)
Analyst Recommendation on Black Diamond Therapeutics Inc Stock
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Black Diamond Therapeutics Inc. Average target price of $9.71
Black Diamond Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Black Diamond Therapeutics Inc.
What analysts predicted
68.49%UPSIDE
Target Price
$9.71
Current Price
$3.06
Analyzed by
12 Analysts
Target
$9.71
Black Diamond Therapeutics Inc target price $9.71, a slight upside of 68.49% compared to current price of $3.06. According to 12 analysts rating.
Black Diamond Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Black Diamond Therapeutics Inc Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Black Diamond Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Black Diamond Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Black Diamond Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Black Diamond Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Black Diamond Therapeutics Inc News & Key Events
Today's Timeline - 03 December
Wed, 08:33 PM
-Black Diamond shares drop 28% after reporting Phase 2 data for Silevertinib in NSCLC and plans for GBM trial.
Insights on Black Diamond Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, BDTX has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 7 days, BDTX stock has moved up by 15.0%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, BDTX has outperformed top 5 stocks with highest market-cap in its industry
About Black Diamond Therapeutics Inc
| Organisation | Black Diamond Therapeutics Inc |
| Headquarters | 245 First Street, Cambridge, MA, United States, 02142 |
| Industry | Biotechnology |
| CEO | Dr. Mark A. Velleca M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Black Diamond Therapeutics Inc
Name | Title |
|---|---|
Ms. Melanie Morrison | Chief Development Officer |
Dr. Mark A. Velleca M.D., Ph.D. | CEO, President & Chairman |
Mr. Brent Hatzis-Schoch Esq., J.D. | COO & General Counsel |
Dr. Sergey Yurasov M.D., Ph.D. | Chief Medical Officer |
Dr. Elizabeth Buck Ph.D. | Co-Founder & Chief Scientific Officer |
Ms. Erika Jones | Principal Financial Officer, Principal Accounting Officer, SVP of Finance & Corporate Controller |
FAQs
What is Black Diamond Therapeutics Inc share price today?
Black Diamond Therapeutics Inc share price today is $3.06 as on at the close of the market. Black Diamond Therapeutics Inc share today touched a day high of $3.17 and a low of $2.98.
What is the 52 week high and 52 week low for Black Diamond Therapeutics Inc share?
Black Diamond Therapeutics Inc share touched a 52 week high of $4.94 on and a 52 week low of $1.39 on . Black Diamond Therapeutics Inc stock price today i.e. is closed at $3.06,which is 38.06% down from its 52 week high and 120.14% up from its 52 week low.
What is Black Diamond Therapeutics Inc's market capitalisation today?
Black Diamond Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Black Diamond Therapeutics Inc Stock (BDTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Black Diamond Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Black Diamond Therapeutics Inc Shares that will get you 0.4902 shares as per Black Diamond Therapeutics Inc share price of $3.06 per share as on April 21, 2026 at 1:29 am IST.
What is the minimum amount required to buy Black Diamond Therapeutics Inc Stock (BDTX) from India?
Indian investors can start investing in Black Diamond Therapeutics Inc (BDTX) shares with as little as ₹93.107 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.07 in Black Diamond Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Black Diamond Therapeutics Inc share’s latest price of $3.06 as on April 21, 2026 at 1:29 am IST, you will get 3.2680 shares of Black Diamond Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Black Diamond Therapeutics Inc has given to Indian investors in the last 5 years?
Black Diamond Therapeutics Inc stock has given -88.32% share price returns and 22.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?